S&P 500
(0.38%) 5 037.57 points
Dow Jones
(0.45%) 38 074 points
Nasdaq
(0.74%) 15 721 points
Oil
(-0.44%) $78.65
Gas
(4.87%) $2.03
Gold
(0.01%) $2 311.20
Silver
(0.13%) $26.78
Platinum
(0.71%) $961.65
USD/EUR
(0.13%) $0.934
USD/NOK
(0.07%) $11.04
USD/GBP
(0.15%) $0.800
USD/RUB
(-1.37%) $91.98

Aktualne aktualizacje dla Opthea Ltd [OPT.AX]

Giełda: ASX Branża: Pharmaceuticals, Biotechnology & Life Sciences
Ostatnio aktualizowano2 geg. 2024 @ 09:10

-1.61% $ 0.610

Live Chart Being Loaded With Signals

Commentary (2 geg. 2024 @ 09:10):

Opthea Limited, a clinical stage biopharmaceutical company, develops and commercializes therapies primarily for eye disease in Australia. The company's development activities are based on the intellectual property portfolio covering Vascular Endothelial Growth Factors (VEGF) VEGF-C, VEGF-D, and VEGF Receptor-3 for the treatment of diseases associated with blood and lymphatic vessel growth, as well as vascular leakage...

Stats
Dzisiejszy wolumen 335 019
Średni wolumen 740 628
Kapitalizacja rynkowa 404.31M
EPS $0 ( 2024-02-27 )
Last Dividend $0.117 ( 2004-10-11 )
Next Dividend $0 ( N/A )
P/E -1.330
ATR14 $0.00100 (0.16%)

Wolumen Korelacja

Długi: -0.04 (neutral)
Krótki: -0.66 (moderate negative)
Signal:(57.067) Neutral

Opthea Ltd Korelacja

10 Najbardziej pozytywne korelacje
10 Najbardziej negatywne korelacje

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Opthea Ltd Korelacja - Waluta/Towar

The country flag -0.16
( neutral )
The country flag -0.04
( neutral )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag -0.13
( neutral )

Opthea Ltd Finanse

Annual 2023
Przychody: $161 163
Zysk brutto: $-89 309.00 (-55.42 %)
EPS: $-0.450
FY 2023
Przychody: $161 163
Zysk brutto: $-89 309.00 (-55.42 %)
EPS: $-0.450
FY 2022
Przychody: $125 047
Zysk brutto: $-107 422 (-85.91 %)
EPS: $-0.340
FY 2021
Przychody: $68 613.00
Zysk brutto: $0.00 (0.00 %)
EPS: $-0.195

Financial Reports:

No articles found.

Opthea Ltd Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)

Opthea Ltd Dividend Information - No Dividend Player

Dividend Sustainability Score: 0.0275 - low (50.00%) | Divividend Growth Potential Score: 0 - No dividend growth expected in the near future
Information
First Dividend $0.117 2004-10-11
Last Dividend $0.117 2004-10-11
Next Dividend $0 N/A
Payout Date 2004-11-01
Next Payout Date N/A
# dividends 1 --
Total Paid Out $0.117 --
Avg. Dividend % Per Year 0.00% --
Score 0.01 --
Div. Sustainability Score 0.0275
Div.Growth Potential Score 0
Div. Directional Score 0 --
Next Divdend (Est)
(2024-05-02)
$0 Estimate 0.00 %
Dividend Stability
0.00 Very Bad
Dividend Score
0.01
Pay Frequency
Insufficient data to determine frequency
Yearly Payout
Year Amount Yield

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for ASX

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
RFF.AX Ex Dividend Knight 2023-09-28 Quarterly 0 0.00%
BRG.AX Ex Dividend Knight 2023-09-13 Semi-Annually 0 0.00%
KSL.AX Ex Dividend Knight 2023-09-06 Semi-Annually 0 0.00%
SRV.AX Ex Dividend Knight 2023-09-04 Semi-Annually 0 0.00%
COH.AX Ex Dividend Knight 2023-09-18 Annually 0 0.00%
MXT.AX Ex Dividend Knight 2023-08-31 Monthly 0 0.00%
WBC.AX Ex Dividend Junior 2023-05-11 Annually 0 0.00%
EHL.AX Ex Dividend Knight 2023-09-07 Sporadic 0 0.00%
PCG.AX Ex Dividend Junior 2023-08-29 Annually 0 0.00%
ALU.AX Ex Dividend Knight 2023-09-04 Semi-Annually 0 0.00%

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM-1 383.771.500-10.00-10.00[0 - 0.5]
returnOnAssetsTTM-1.4671.200-10.00-10.00[0 - 0.3]
returnOnEquityTTM8.771.50010.0010.00[0.1 - 1]
payoutRatioTTM0-1.00000[0 - 1]
currentRatioTTM5.100.80010.008.00[1 - 3]
quickRatioTTM5.000.80010.008.00[0.8 - 2.5]
cashRatioTTM4.821.50010.0010.00[0.2 - 2]
debtRatioTTM0.000780-1.5009.99-10.00[0 - 0.6]
interestCoverageTTM-8.081.000-4.10-4.10[3 - 30]
operatingCashFlowPerShareTTM-0.3062.00-0.102-0.204[0 - 30]
freeCashFlowPerShareTTM-0.3062.00-0.153-0.306[0 - 20]
debtEquityRatioTTM-0.00277-1.500-0.01110.0166[0 - 2.5]
grossProfitMarginTTM0.5561.0004.074.07[0.2 - 0.8]
operatingProfitMarginTTM-1 413.431.000-10.00-10.00[0.1 - 0.6]
cashFlowToDebtRatioTTM-1 397.121.000-10.00-10.00[0.2 - 2]
assetTurnoverTTM0.001060.800-3.33-2.66[0.5 - 2]
Total Score0.0275

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM-1.4921.000-0.2520[1 - 100]
returnOnEquityTTM8.772.5010.0010.00[0.1 - 1.5]
freeCashFlowPerShareTTM-0.3062.00-0.102-0.306[0 - 30]
dividendYielPercentageTTM01.50000[0 - 0.4]
operatingCashFlowPerShareTTM-0.3062.00-0.102-0.204[0 - 30]
payoutRatioTTM01.50000[0 - 1]
pegRatioTTM0.007401.500-3.280[0.5 - 2]
operatingCashFlowSalesRatioTTM-1 027.631.000-10.000[0.1 - 0.5]
Total Score-0.559

Opthea Ltd

Opthea Limited, a clinical stage biopharmaceutical company, develops and commercializes therapies primarily for eye disease in Australia. The company's development activities are based on the intellectual property portfolio covering Vascular Endothelial Growth Factors (VEGF) VEGF-C, VEGF-D, and VEGF Receptor-3 for the treatment of diseases associated with blood and lymphatic vessel growth, as well as vascular leakage. Its lead asset is OPT 302, a soluble form of VEGFR 3 in clinical development as a novel therapy for wet neovascular age related macular degeneration and diabetic macular edema (DME), as well as a first in class VEGF-C/D inhibitors for treatment with VEGF-A inhibitors to treat wet neovascular AMD and other retinal diseases. The company was formerly known as Circadian Technologies Limited and changed its name to Opthea Limited in December 2015. Opthea Limited was incorporated in 1984 and is based in South Yarra, Australia.

O Sygnały na żywo

Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.

Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej